In patients with HF, long-term usage of β-AR blockers reduced the metabolic demand of oxygen on the heart and lowered oxidative stress and ROS damage [102,396,397,398,399,400,401,402]. The gene discussed is ADRB2; the disease is hydrops fetalis.